Cargando…

Effect of Flaxseed Powder on Cardiovascular Risk Factor in Dyslipidemic and Hypertensive Patients

BACKGROUND: Hyperlipidemia and hypertension are the most important causes of ischemic heart disease. There is evidence that flaxseed powder can improve lipid profile and blood pressure. In this study, we want to investigate the effects of flaxseed powder consumption on patients with hyperlipidemia a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haghighatsiar, Naemeh, Askari, Gholamreza, Saraf-Bank, Sahar, Feizi, Avat, Keshmiri, Hasan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6941378/ https://www.ncbi.nlm.nih.gov/pubmed/31929865 http://dx.doi.org/10.4103/ijpvm.IJPVM_563_17

Ejemplares similares

Depression contributing to dyslipidemic cardiovascular risk in the metabolic syndrome
por: Lemche, A. V., et al.
Publicado: (2016)

Effects of curcumin on cardiovascular risk factors in obese and overweight adolescent girls: a randomized clinical trial
por: Saraf-Bank, Sahar, et al.
Publicado: (2019)

Does Alpha-lipoic Acid Supplementation Modulate Cardiovascular Risk Factors in Patients with Stroke? A Randomized, Double-blind Clinical Trial
por: Mohammadi, Vida, et al.
Publicado: (2018)

The Influence of Flaxseed Oil Cake Extract on Oxidative Stability of Microencapsulated Flaxseed Oil in Spray-Dried Powders
por: Drozłowska, Emilia, et al.
Publicado: (2021)

The characteristics of pre-diabetic patients associated with body composition and cardiovascular disease risk factors in the Iranian population
por: Gholi, Zahra, et al.
Publicado: (2016)

Association between Sun Exposure, Vitamin D Intake, Serum Vitamin D Level, and Immunoglobulin G Level in Patients with Neuromyelitis Optica Spectrum Disorder
por: Shaygannejad, Vahid, et al.
Publicado: (2018)

Healthy eating index and cardiovascular risk factors among Iranian elderly individuals
por: Rashidipour-Fard, Nafiseh, et al.
Publicado: (2017)

Addressing dyslipidemic risk beyond LDL-cholesterol
por: Tall, Alan R., et al.
Publicado: (2022)

Effect of garlic powder consumption on body composition in patients with nonalcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial
por: Soleimani, Davood, et al.
Publicado: (2016)

Association of modified Nordic diet with cardiovascular risk factors among type 2 diabetes patients: a cross-sectional study
por: Daneshzad, Elnaz, et al.
Publicado: (2018)

Dyslipidemic drugs in metabolic syndrome
por: Siddiqi, Sheelu S., et al.
Publicado: (2013)

Association of retinol-binding protein 4 with metabolic syndrome in first-degree relatives of type 2 diabetic patients
por: Tabesh, Marjan, et al.
Publicado: (2017)

Improvement of antioxidant status after Brazil nut intake in hypertensive and dyslipidemic subjects
por: Huguenin, Grazielle V. B., et al.
Publicado: (2015)

Changes in the quality of flaxseed oil powder produced by incorporating with microcrystalline cellulose and thyme
por: Farhoudpour, Mahsa, et al.
Publicado: (2023)

Predicting of perceived self efficacy in the amount of macronutrients intake in women with metabolic syndrome - 2012
por: Mohebi, Siamak, et al.
Publicado: (2014)

Review the key role of self-efficacy in diabetes care
por: Mohebi, Siamak, et al.
Publicado: (2013)

Structural role of perceived benefits and barriers to self-care in patients with diabetes
por: Mohebi, Siamak, et al.
Publicado: (2013)

Flaxseed Can Reduce Hypoxia-Induced Damages in Rat Testes
por: Poorhassan, Mahnaz, et al.
Publicado: (2018)

Cardiac Mitochondria Dysfunction in Dyslipidemic Mice
por: Braczko, Alicja, et al.
Publicado: (2022)

The effect of flaxseed supplementation on sex hormone profile in adults: a systematic review and meta-analysis
por: Musazadeh, Vali, et al.
Publicado: (2023)

Cardiovascular risk assessment of dyslipidemic middle-aged adults without overt cardiovascular disease over the period of 2009–2016 in Lithuania
por: Kutkiene, Sandra, et al.
Publicado: (2018)

Risk factors and quality of life of dyslipidemic patients in Lebanon: A cross-sectional study
por: Farhat, Akram, et al.
Publicado: (2016)

Prevalence of pre-hypertension and hypertension, awareness, treatment, and control of hypertension, and cardiovascular risk factors in postmenopausal women
por: Eghbali-Babadi, Maryam, et al.
Publicado: (2021)

Pharmacokinetic interaction of garlic and atorvastatin in dyslipidemic rats
por: Reddy, G. Dilip, et al.
Publicado: (2012)

Serum lysophospholipid levels are altered in dyslipidemic hamsters
por: Suárez-García, Susana, et al.
Publicado: (2017)

Potential benefits of L. acidophilus in dyslipidemic rats
por: Reamtong, Onrapak, et al.
Publicado: (2021)

TRC210258, a novel TGR5 agonist, reduces glycemic and dyslipidemic cardiovascular risk in animal models of diabesity
por: Zambad, Shitalkumar P, et al.
Publicado: (2013)

Trials in “True” Dyslipidemic Patients Are Urged to Reconsider Comprehensive Lipid Management as a Means to Reduce Residual Cardiovascular Risk
por: Werba, José P., et al.
Publicado: (2019)

The effect of dyslipidemic drugs on mortality: A meta-analysis
por: Jain, Shuchi, et al.
Publicado: (2009)

Impact of weight loss diet associated with flaxseed on inflammatory markers in men with cardiovascular risk factors: a clinical study
por: Cassani, Roberta Soares Lara, et al.
Publicado: (2015)

Anaphylaxis caused by flaxseed
por: Lleonart, Ramon, et al.
Publicado: (2015)

Dietary intakes and leptin concentrations
por: Izadi, Vajiheh, et al.
Publicado: (2014)

Association of Maternal Serum Vitamin D Level with Risk of Pregnancy-Related Complications and Neonatal Anthropometric Measures: A Prospective Observational Study
por: Hajianfar, Hossein, et al.
Publicado: (2019)

Interleukin-1-Beta and Dyslipidemic Syndrome as Major Risk Factors for Thrombotic Complications in Type 2 Diabetes Mellitus
por: Bădulescu, Oana, et al.
Publicado: (2013)

Effect of Garlic and Lemon Juice Mixture on Lipid Profile and Some Cardiovascular Risk Factors in People 30-60 Years Old with Moderate Hyperlipidaemia: A Randomized Clinical Trial
por: Aslani, Negar, et al.
Publicado: (2016)

LDL Particle Size and Reactive Oxygen Metabolites in Dyslipidemic Patients
por: Kotani, Kazuhiko, et al.
Publicado: (2012)

Grape juice attenuates left ventricular hypertrophy in dyslipidemic mice
por: Martins, Ângela Maria, et al.
Publicado: (2020)

The Link between Magnesium Supplements and Statin Medication in Dyslipidemic Patients
por: Nartea, Roxana, et al.
Publicado: (2023)

Variations in the structural and functional properties of flaxseed gum from six different flaxseed cultivars
por: Ren, Xuejiao, et al.
Publicado: (2021)

The effect of flaxseed powder on insulin resistance indices and blood pressure in prediabetic individuals: A randomized controlled clinical trial
por: Javidi, Afrooz, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_kpbsoqnkudvg91frvdl35g2amv